A Phase I Study of SB26 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

April 16, 2020

Study Completion Date

April 16, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

SB26

SB26 administered intravenously

DRUG

Placebo

Placebo administered intravenously

Trial Locations (1)

PAREXEL International, Glendale

All Listed Sponsors

lead

Samsung Bioepis Co., Ltd.

INDUSTRY

NCT03630627 - A Phase I Study of SB26 in Healthy Volunteers | Biotech Hunter | Biotech Hunter